The 20 Best Muscle Invasive Bladder Cancer Doctors Near Me in Bethpage, NY

Anthony Corcoran is an Oncologist practicing medicine in Garden City, New York. Dr. Corcoran is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Vasectomy.

Jeffrey Layne is a Urologist practicing medicine in Plainview, New York. Dr. Layne is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), Prostatectomy, and Ureteroscopy. Dr. Layne is board certified in American Board Of Urology.

Matthew Mene is a Urologist practicing medicine in Seaford, New York. Dr. Mene is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Perirenal Abscess, Carbuncle, Ureteroscopy, and Prostatectomy.

Jeffrey Haberman is a Urologist practicing medicine in Plainview, New York. Dr. Haberman is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Prostatectomy. Dr. Haberman is board certified in American Board Of Urology.

Robert Luntz is a Urologist practicing medicine in Plainview, New York. Dr. Luntz is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Ochoa Syndrome, Enlarged Prostate (BPH), Urinary Tract Infection in Children, Ureteroscopy, and Prostatectomy.

Tara Liberman is a Palliative Medicine specialist and an Internal Medicine provider practicing medicine in Woodbury, New York. Dr. Liberman is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her clinical expertise encompasses Muscle Invasive Bladder Cancer and Non-Muscle Invasive Bladder Cancer. Dr. Liberman is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, and American Board Of Internal Medicine/Geriatric Medicine.

Hon Chan is a Hematologist and an Oncologist practicing medicine in Woodbury, New York. Dr. Chan is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Drug-Induced Thrombocytopenia, Glossitis, Pernicious Anemia, and Vitamin B12 Deficiency.

Jackie Orfanos is a primary care provider, practicing in Internal Medicine in Plainview, New York. Dr. Orfanos is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Generalized Anxiety Disorder (GAD), Insomnia, High Cholesterol, and Obesity in Children. Dr. Orfanos is currently accepting new patients.

Salvatore Trazzera is a Cardiologist practicing medicine in Farmingdale,, New York. Dr. Trazzera is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Heart Murmurs, Vertigo, Familial Neurocardiogenic Syncope, and Transient Ischemic Attack (TIA).

Theodore Felderman is a Urologist practicing medicine in Plainview, New York. Dr. Felderman is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses UPJ Obstruction, Retroperitoneal Fibrosis, Bilateral Hydronephrosis, Enlarged Prostate (BPH), and Ureteroscopy.

Jed Hantverk is a primary care provider, practicing in Hospital Medicine in Hicksville, New York. Dr. Hantverk is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.

Tso-jen Hsiao is a Urologist practicing medicine in Plainview, New York. Dr. Hsiao is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, Enlarged Prostate (BPH), and Ureteroscopy.

Roger Lao is a Radiologist practicing medicine in Woodbury, New York. Dr. Lao is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Angiomyoma, Uterine Fibroids, Visceromegaly, and Retroversion of the Uterus.

Anita Ankola is a Radiologist practicing medicine in Seaford, New York. Dr. Ankola is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her clinical expertise encompasses Biliary Dyskinesia, Visceromegaly, Gallbladder Disease, and Carbuncle.

Paul Lang is a Radiologist practicing medicine in Massapequa, New York. Dr. Lang is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Visceromegaly, Angiomyoma, Uterine Fibroids, and Non-Alcoholic Fatty Liver Disease.

Reza Ghavamian is an Oncologist and a Urologist practicing medicine in Greenlawn, New York. Dr. Ghavamian is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Ghavamian is board certified in American Board Of Urology.

Dr. Simon J Hall MD is a board certified urologist with Fellowship training in Urologic Oncology. His clinical interests include the diagnosis and treatment of Prostate, Bladder and Kidney cancers. He is especially interested in Active Surveillance of men with prostate cancer and men and women with incidentally found small renal masses and the creation of continent urinary reconstructions for patients who need to undergo cystectomy for Bladder cancer. Furthermore, Dr. Hall has a keen interest in treating patients with recurrent prostate cancer following definitive therapy. He believes that objective & balanced communication with the patient and family is the key to decision making and individualized care. Over the years Dr. Hall has been named as Best Doctor, both nationally and regionally, by organizations such as Castle Connolly, SuperDoctors and New York Magazine. Dr. Hall s research has focused of new therapies for prostate and bladder cancer; he has participated in numerous clinical trials, some of which generated data resulting in FDA approval of Sipleucel-T (Provenge) and enzulutamide (Xtandi). He oversees a laboratory investigating novel approaches to negating the Androgen Receptor, an important key driver of castration resistant prostate cancer. Decision making and improved methods of clinical care for patients with bladder and prostate cancer are important aspects of his research interests in collaboration with Dr. Michael Diefenbach, a behavioral scientist in the Departments of Urology & Medicine at NS-LIJ. He has authored or co-authored nearly 70 peer reviewed articles in Journals such as Journal of Urology, Urology, British Journal of Urology, Clinical Cancer Research and Science. Dr. Hall received his MD from the College of Physicians & Surgeons of Columbia University. He then completed two years of Surgery training at the Mount Sinai Medical Center followed by a four year residency in Urology at Boston University School of Medicine. This was followed by a 2 year fellowship in Urologic Oncology in the Scott Department of Urology at Baylor College of Medicine. Prior to joining the Smith Institute for Urology, he served on the faculty of Icahn School of Medicine at Mount Sinai for 18 years, holding various positions including Kyung Hyun Kim MD Chair of Urology and the Director of the Deane Prostate Health & Research Center. Dr. Hall is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hall is board certified in American Board Of Urology.

Joph Steckel is a Urologist practicing medicine in Lake Success, New York. Dr. Steckel is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Steckel is board certified in American Board Of Urology.

As Senior Vice President of the Urology Service Line, Chair of theSmith Institute for Urology, and Chair of Urology at the Zucker Schoolof Medicine at Hofstra/Northwell, Samir Taneja, MD will establish hisclinical practice at Lenox Hill Hospital and Long Island Jewish MedicalCenter focused on the surgical management of prostate cancerand renal tumors. He is an expert in urologic oncology, renowned fortransforming the field of prostate cancer diagnosis and treatmentby improving methods of prostate imaging, cancer detection, anddisease localization. Having performed thousands of robotic, ablative,laparoscopic and open surgical procedures, his specific clinical focushas been in improving prostate cancer patient outcomes throughpioneering techniques for focal ablative therapy, refining surgicaltechniques for robotic prostatectomy and partial nephrectomy,devising accelerated recovery pathways for robotic prostatectomy/partial nephrectomy, and providing muti-modal surgical approachesfor patients with high risk and recurrent prostate cancer. As leader ofthe department, he will strive to ensure individualized care of urologicdisease through state-of-the-art surgical approaches and multi-disciplinary care.Prior to joining Northwell, Dr Taneja was a faculty member of NYUGrossman School of Medicine for 29-years as a tenured professorof urology, radiology, and biomedical engineering. Most recently heserved as Director of the Division of Urologic Oncology and ViceChair in the Department of Urology at NYU Langone Health, as well asGenitourinary Program Leader in the Perlmutter Cancer Center.Dr. Taneja has conducted extensive clinical research on the use ofimaging in prostate cancer and is considered a pioneer in the use ofMRI to diagnose and localize prostate cancer and the emerging field ofprostate cancer focal therapy. He has authored more than 250 articles,30 book chapters, and six textbooks and monographs on urologiccancer and surgery. He is the editor of Taneja's Complications ofUrologic Surgery: Prevention and Diagnosis, one of the most widely readtextbooks in American Urology. Dr. Taneja is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Taneja is board certified in American Board Of Urology.

"Xinhua Zhu, MD, PhD, is a medical oncologist and hematologist at Monter Cancer Center, where he specializes in treating genitourinary cancer, including cancer of the prostate, kidney, bladder and testicles. He focuses on compassionate, evidence-based care, rooted in his research background.""My research helps me think outside the box when creating treatment plans,"" says Dr. Zhu, ""and enables me to explain to patients the mechanisms behind the treatments I'm using."" His research interests include finding new treatment targets for generating hormone resistance in prostate cancer and metastatic castration-resistant prostate cancer, exploring biomarkers in bladder cancer to guide decisions about chemotherapy, exploring the mechanisms for kidney cancer metastasis, and investigating the effectiveness of immunotherapy for genitourinary cancers.Dr. Zhu earned his medical degree at Suzhou Medical College and practiced internal medicine in China. He obtained his PhD in cancer study at Shanghai Jiao Tong University School of Medicine, then moved to the United States for postdoctoral research training at Memorial Sloan Kettering Cancer Center, an internal medicine residency at Mount Sinai School of Medicine. He attended NYU School of Medicine for fellowship training in hematology and medical oncology.In 2013, he joined Northwell Health, where he regularly meets with a multidisciplinary group of pathologists, radiologists, radiation oncologists, surgical oncologists, geneticists and the Molecular Tumor Board to create treatment plans.As an associate professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, he twice received the Medical Oncology/Hematology Fellowship Program Teacher of the Year Award. Dr. Zhu is also a phase 1 cancer research program director at Monter Cancer Center. He is assistant investigator at the Feinstein Institutes for Medical Research, and a member of the American Society of Clinical Oncology, the American Association of Cancer Research, and the Principal Investigator for the Northwell Health NCI Community Oncology Research Program (NCORP)For Dr. Zhu, being able to pursue both scientific investigation and patient care is the best part of his work. ""I can take research from the bench to the bedside, providing people with the best possible treatments,"" he says.". Dr. Zhu is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, and Clear Cell Sarcoma. Dr. Zhu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.